540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Performance
- Low
- ₹62
- High
- ₹65
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹65
- Previous Close₹64
- Volume1,864
Investment Returns
- Over 1 Month -12.94%
- Over 3 Month -7.63%
- Over 6 Month + 13.17%
- Over 1 Year + 1.87%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.1
- PEG Ratio
- 0
- Market Cap Cr
- 65
- P/B Ratio
- 4.5
- Average True Range
- 4.03
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.14
- RSI
- 46.34
- MFI
- 20.87
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹63.06
-1.38
(-2.14%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹65.07
- 50 Day
- ₹64.84
- 100 Day
- ₹64.14
- 200 Day
- ₹62.68
Resistance and Support
63.51
- R3 67.37
- R2 66.07
- R1 64.81
- S1 62.25
- S2 60.95
- S3 59.69
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results | |
| 2024-11-12 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹63 As on 03 January, 2026 | 18:18
The Market Cap of Aspira Pathlab & Diagnostics is ₹64.9 Cr As on 03 January, 2026 | 18:18
The P/E ratio of Aspira Pathlab & Diagnostics is 19.1 As on 03 January, 2026 | 18:18
The PB ratio of Aspira Pathlab & Diagnostics is 4.5 As on 03 January, 2026 | 18:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.